hotspot -WSS

hotspot

author：hotspot 2025-09-29 01:09:02 - browse：464

Matts Take Column Illustration — Molly Ferguson for STAT

What do you say to a patient when the FDA rejects “their” experimental drug — one that they believe can alleviate at least some of their suffering?

That question arises in the aftermath of a dramatic moment at the Food and Drug Administration last week. Over the FDA’s protests, a small biotechnology company called BrainStorm Cell Therapeutics had insisted that the agency evaluate its experimental treatment for amyotrophic lateral sclerosis, or ALS, brand named NurOwn. ALS patients made fervent pleas for the medicine, a type of stem cell preparation, based on reports on social media and re-analyses of the data that they thought indicated it might be of some help to those with the fatal disease.

But the FDA methodically dismantled BrainStorm’s application. The medicine couldn’t work the way the company said it would, the agency insisted; the clinical trials didn’t show it was effective; and it was not clear BrainStorm could manufacture the medicine with sufficient quality. Worst of all, more patients died among those who received the drug than those who got placebo. The FDA’s panel of expert advisers voted 17 to 1 that the medicine was not safe and effective, with one person abstaining. The agency doesn’t have to follow the panel’s advice but probably will.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： UpToDate has a racism problem: Dr. Stanley Goldfarb

WSS

STAT wants to know your pick for a great summer read or listen

Undocumented workers face uncertainty as immigration law takes effect in Florida

Use doctors trained outside the U.S. to ease the physician shortage

STAT Boddities: What happens to the brain when we get scared?

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

focus

hotspot

hotspot

Heart attack and stroke risk calculators need revising

Artificial intelligence use in health care faces greater scrutiny in 2024

Affirmative action in medical school literally saved lives

What affirmative action's end means to a medical student

Alkermes shareholders re

Why don't Americans have at

Cancer drug shortages should be causing more outrage

STAT Boddities: What happens to the brain when we get scared?

Cancer drug shortages should be causing more outrage

STAT Boddities: What happens to the brain when we get scared?

hotspot

Hubble vs. James Webb telescope images: See the difference

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

AstraZeneca lung cancer study comes in below expectations

Bernie Sanders gets little from pharma CEOs on drug prices

Websites selling Wegovy, Zepbound ingredients targeted by FDA

Drug cartel violence flares in western Mexico after vigilante leader's killing

focus

hotspot

Wikipedia

explore